Sign In
Buy GMAB
$23.88
+0.0300 (+0.126%)
At Close: Jun 03, 2026
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
08:26pm, Monday, 04'th Jan 2021
Company Announcement
Genmab Announces Phase 3 Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer
02:00pm, Monday, 04'th Jan 2021
Media Release COPENHAGEN, Denmark, Jan. 04, 2021
Genmab: An European R&D Behemoth With Long-Term Potential
11:25am, Wednesday, 23'rd Dec 2020
Genmab is a well-managed and vast European biopharma R&D giant. Its partnered products and self-owned pipelines are vast.
Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab
05:01pm, Tuesday, 15'th Dec 2020
Company Announcement
A Trio of Stock Picks for the Value Investor
09:18am, Sunday, 29'th Nov 2020
If you are looking for potential value opportunities amid U.S.-listed equities, picking stocks that meet the following three criteria represent a solid starting point, in my opinion:
Capital Increase in Genmab as a Result of Employee Warrant Exercise
02:57pm, Tuesday, 10'th Nov 2020
Company Announcement
Media Release Copenhagen, Denmark, November 5, 2020
Genmab A/S (GMAB) CEO Jan van de Winkel on Q3 2020 Results - Earnings Call Transcript
02:13am, Thursday, 05'th Nov 2020
Genmab A/S (GMAB) CEO Jan van de Winkel on Q3 2020 Results - Earnings Call Transcript
Genmab Announces Financial Results for the First Nine Months of 2020
11:04am, Wednesday, 04'th Nov 2020
November 4, 2020; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2020
Genmab Announces Data to be Presented at 2020 ASH Annual Meeting
10:13am, Wednesday, 04'th Nov 2020
Media Release Copenhagen, Denmark, November 4, 2020
Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami)
07:15am, Friday, 30'th Oct 2020
COPENHAGEN, Denmark & LAUSANNE, Switzerland--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) and ADC Therapeutics SA (NYSE: ADCT) today announced that they have executed an amended agreement for ADC Therap
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
10:49am, Friday, 11'th Sep 2020
Halvorsen's 13F portfolio value increased from $19.21B to $23.14B. The number of positions increased from 64 to 71.
BMEZ: Continuing To Weather The Pandemic Storm
11:38am, Wednesday, 19'th Aug 2020
BMEZ is a fund that is focused on the healthcare space, more specifically, a focus on the health sciences industry.
Capital Increase in Genmab as a Result of Employee Warrant Exercise
07:40pm, Tuesday, 18'th Aug 2020
Company AnnouncementCopenhagen, Denmark; August 18, 2020 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 62,716 shares as a consequence of the exercise of employee warrants.The increa
